- Home
- UTHR vs HRL Comparison
UTHR vs HRL Comparison
Compare UTHR & HRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UTHR
- HRL
- Stock Information
- Founded
- UTHR 1996
- HRL 1891
- Country
- UTHR United States
- HRL United States
- Employees
- UTHR N/A
- HRL N/A
- Industry
- UTHR Biotechnology: Pharmaceutical Preparations
- HRL Meat/Poultry/Fish
- Sector
- UTHR Health Care
- HRL Consumer Staples
- Exchange
- UTHR Nasdaq
- HRL Nasdaq
- Market Cap
- UTHR 16.1B
- HRL 15.7B
- IPO Year
- UTHR 1999
- HRL N/A
- Fundamental
- Price
- UTHR $361.10
- HRL $29.65
- Analyst Decision
- UTHR Buy
- HRL Hold
- Analyst Count
- UTHR 13
- HRL 5
- Target Price
- UTHR $382.08
- HRL $32.40
- AVG Volume (30 Days)
- UTHR 385.3K
- HRL 3.1M
- Earning Date
- UTHR 02-26-2025
- HRL 02-27-2025
- Dividend Yield
- UTHR N/A
- HRL 3.91%
- EPS Growth
- UTHR 25.10
- HRL 1.29
- EPS
- UTHR 22.72
- HRL 1.47
- Revenue
- UTHR $2,756,200,000.00
- HRL $11,920,797,000.00
- Revenue This Year
- UTHR $26.10
- HRL $2.22
- Revenue Next Year
- UTHR $10.43
- HRL $2.28
- P/E Ratio
- UTHR $15.89
- HRL $20.19
- Revenue Growth
- UTHR 25.04
- HRL N/A
- 52 Week Low
- UTHR $218.41
- HRL $28.03
- 52 Week High
- UTHR $417.82
- HRL $36.86
- Technical
- Relative Strength Index (RSI)
- UTHR 48.08
- HRL 51.15
- Support Level
- UTHR $364.62
- HRL $28.03
- Resistance Level
- UTHR $383.51
- HRL $28.85
- Average True Range (ATR)
- UTHR 11.17
- HRL 0.51
- MACD
- UTHR 1.30
- HRL 0.06
- Stochastic Oscillator
- UTHR 42.76
- HRL 84.37
About UTHR United Therapeutics Corporation
United Therapeutics specializes in drug development for pulmonary arterial hypertension, a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. Most of the company's sales are generated within the United States. United Therapeutics also markets a pediatric oncology drug, but its focus largely remains in pulmonary arterial hypertension.
About HRL Hormel Foods Corporation
Historically meat-focused, Hormel Foods broadened its lineup to include other protein offerings and become a branded food company. The firm sells its wares through multiple channels, including US retail (62% of fiscal 2024 sales), US food service (32%), and international (6%). By product, 72% of fiscal 2024 sales were from perishable food and 28% from shelf-stable. Major brands include Hormel, Spam, Jennie-O, Columbus, Applegate, Planters, and Skippy. Many of these hold the number one or two market share in their respective categories.